506
Participants
Start Date
October 11, 2020
Primary Completion Date
October 18, 2024
Study Completion Date
January 9, 2025
active intervention
The antibiotic prophylaxis will be cefazolin 2 g, or piperacilline-tazobactam 4 g, powder for solution for injection diluted in 50mL of NaCl 0.9%, IV infusion on 30 minutes with syringe pump.
placebo intervention
The control group will received, as placebo NaCl 0.9% solution for injection diluted in 50mL of NaCl 0.9%, IV infusion on 30 minutes with syringe pump.
RECRUITING
Saint Louis Hospital, Paris
Assistance Publique - Hôpitaux de Paris
OTHER